Supplemental Table S3 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens
Authors:
- Josep TaberneroJTJosep Tabernero
- Philippe L. BedardPBPhilippe L. Bedard
- Yung-Jue BangYung-Jue Bang
- Maria VieitoMVMaria Vieito
- Min-Hee RyuMRMin-Hee Ryu
- Nathalie FagniezNFNathalie Fagniez
- Mustapha ChadjaaMCMustapha Chadjaa
- Christine SouffletCSChristine Soufflet
- Nina MassonNMNina Masson
- Anas GazzahAGAnas Gazzah
Open Access
- 28 August 2023
- other
- Published by American Association for Cancer Research (AACR)